Nvidia-Backed Iambic Therapeutics Files for US IPO

Iambic Therapeutics, an AI-driven biotech company backed by Nvidia, has filed for an initial public offering (IPO) in the US.

The company's move to go public marks a significant milestone for Iambic, which aims to revolutionize drug development using artificial intelligence and machine learning.

Iambic Therapeutics is working on developing new treatments for various diseases, including cancer and neurodegenerative disorders. The company has received support from Nvidia, a leading technology firm in the field of artificial intelligence.